Discover 1,107 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alabama provides a diverse range of research opportunities for healthy volunteers and individuals with specific health conditions. Leading research centers in Birmingham, Montgomery, and Mobile are seeking participants, offering access to innovative treatments and cutting-edge medical care.
Filter
1
Filter results
Results: 1,107
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention
for
HIV Seropositivity
Location: Huntsville AL, Birmingham AL, Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18 - 49
Code: NCT05723653
Recruiting
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
for
Rhinovirus Infection
Location: Brooklyn NY, Hamilton NJ, Binghamton NY, Lutherville MD,
Sponsor: Altesa Biosciences, Inc.
Sex: All
Age: 40 - 70+
Code: NCT07610395
Phase2, Recruiting
Menopausal HT for Women Living With HIV (HoT)
for
HIV Infection, Menopause
Location: Boston MA, New York NY, Newark NJ, Philadelphia PA,
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Sex: Female
Age: 40 - 60
Code: NCT06856174
Recruiting
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
for
Peripheral Artery Disease (PAD)
Location: Mooresville NC, Tampa FL, Crystal River FL,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07318610
Phase3, Recruiting
An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
for
Phelan-McDermid Syndrome
Location: Brookline MA, Lexington MA, New York NY, Chevy Chase MD,
Sponsor: Neuren Pharmaceuticals Limited
Sex: All
Age: 3 - 12
Code: NCT07593391
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Boston MA, The Bronx NY, Wilkes-Barre PA, Syracuse NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase2, Recruiting
Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization
for
Emergencies
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 0
Code: NCT06565390
Recruiting
Video Inspired Discussions About Ethical Outcomes in Pediatrics
for
Pediatric Cancer
Location: Boston MA, Atlanta GA, Birmingham AL
Sponsor: Massachusetts General Hospital
Sex: All
Age: 0+
Code: NCT06786104
Recruiting
How Osteopathic Treatment Affects the Leg and Foot in People With Low Back Pain
for
Chronic Low Back Pain (CLBP)
Location: Auburn AL
Sponsor: Edward Via Virginia College of Osteopathic Medicine
Sex: All
Age: 18 - 65
Code: NCT07193212
Recruiting
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
for
Acute Myeloid Leukaemia (AML)
Location: Providence RI, Morristown NJ, Philadelphia PA, Miami FL,
Sponsor: Moleculin Biotech, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06788756
Phase2, Phase3, Recruiting
DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC
for
Non Small Cell Lung Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT06364917
Phase2, Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma